NEW STUDY – shows that Sorbact® Surgical dressing is a cost-effective way to prevent surgical site infection
Surgical site infections (SSI) are common after cesarean section, and can lead to higher morbidity rates, prolonged hospitalization, and an increased number of hospital readmissions.1
A recently published study among 543 women undergoing elective or emergency low transverse cesarean section showed that the risk of SSI was significantly reduced with Sorbact® Surgical Dressing compared to a standard surgical dressing.2
This randomized controlled trial confirmed the efficacy and cost-effectiveness of Sorbact® Surgical Dressing in SSI prevention among women undergoing cesarean section.
References: 1. Jenks PJ, Laurent M, et al. Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital. J Hosp Infect 2014; 86:24-33. 2. Stanirowski PJ, Bizon M, et al. Randomized Controlled Trial Evaluating Dialkylcarbamoyl Chloride (DACC) Impregnated Dressings for the Prevention of Surgical Site Infections in Adult Women Undergoing Cesarean Section. Hosp Infect Epid 2016; [in press]